Aakaar Medical Technologies
- Market cap
- ₹ 90 Cr.
- P/E
- 14.9x
- P/B
- 1.74x
- 52-week range
- 46 – 89.95
- ROE
- 17%
- ROCE
- 18.5%
- Dividend yield
- 0%
- Debt / equity
- 0.34
- Sector
- Personal Products
- Industry
- Personal Care
- Listed on
- NSE SME
About
Aakaar Medical Technologies Limited is an India-based medical aesthetic company. The Company deals in a range of aesthetic & specialized cosmetic products & devices. Its product range includes both its own brands (domestically manufactured products & internationally manufactured devices) and imported brands (distribution of imported brands) from countries such as Korea, Spain, Italy, and Austria. It supplies its products and devices primarily to dermatologists, plastic surgeons, and aesthetic physicians, who then sell these products to their end consumers as well as use certain device consumables as part of their treatments. Its products include Lytec Cream, Lytec Gluta, Lytec HYDRA, Lytec Nano C20, Lytec Klense, Lytec SHELL SUNSCREEN, MELINE 02 Dark Circles, MELINE 00 PREP, MELINE 01 Dark Circles, MELINE 01 Ethnic Skin, MELINE 01 ID, MELINE 01 INTIMATE, MELINE 05 PIGMENT HOME MASK, Swyada Snail Mask, Theraderm Aloe soothing complex, TUBELiTE Gold, Regenera Activa AMT, and others.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Personal Care: 22 companies →Aakaar Medical Technologies against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)14.9 against a typical 33.9: cheaper than most peers (1st = cheapest).5th of 22
- Share price, 3 months+2.9% against a typical −7.5%.5th of 19
- Size₹ 90.4 Cr. market value against a typical ₹ 188.1 Cr. (1st = largest).13th of 19
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 30 Oct 2026Upcoming | Financial Results/Other business matters | 1. To consider and approve the financial results for the period ended September 30, 2026 2. ESOPs to Employees |
| 25 May 2026 | Other business matters | AAKAAR : 25-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 22, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 25, 2026, To consider and approve the ESOP Scheme and other matters |
| 22 May 2026 | Other business matters | To consider and approve the proposal for introduction of Employee Stock Option Scheme ( ESOP Scheme ) and increase in the Authorised Share Capital of the Company, subject to necessary approvals. |
| 15 May 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2026 and other business matters |
| 10 Nov 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2025 and other business matters |
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 34 | 25 | 42 |
| Expenses | 26 | 26 | 31 |
| Operating Profit | 8 | −0 | 10 |
| OPM % | 24.7% | −0.9% | 25% |
| Other Income | 0 | 0 | 1 |
| Interest | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 |
| Profit before tax | 7 | −1 | 10 |
| Tax % | 25.5% | −23.5% | 27.3% |
| Net Profit | 6 | −1 | 7 |
| EPS in Rs | 5.34 | −0.55 | 5.24 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 40%
- 3 Years
- 27%
- TTM
- 9%
- 10 Years
- —
- 5 Years
- 65%
- 3 Years
- 46%
- TTM
- 10%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- 23%
- 3 Years
- 23%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Aakaar Medical Technologies | ₹ 69.95 | ₹ 90 Cr. | 14.9x | 1.7x | 17% | — |
| Le Travenues Technology | ₹ 145.60 | ₹ 6,425 Cr. | 78x | 3x | — | 6.8% |
| Thomas Cook (India) | ₹ 88.37 | ₹ 4,171 Cr. | 21.2x | 1.8x | — | 2.6% |
| Easy Trip Planners | ₹ 5.59 | ₹ 2,224 Cr. | — | 2.6x | — | −12.5% |
| Yatra Online | ₹ 76.85 | ₹ 1,204 Cr. | 29.4x | 1.8x | — | 3.2% |
| Kaya | ₹ 280.60 | ₹ 426 Cr. | — | — | — | −42.3% |
Management
- Rahul Babasaheb Sawakhande
- Chief Executive Officer, Executive Director
- Sweta Shah
- Chief Financial Officer
- Anoopkumar Vishwanathan Pillai
- Company Secretary, Compliance Officer
- Dilip Ramesh Meswani
- Managing Director, Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.